The Korean government said its funding to hospitals for surgeries on severely ill children will drastically increase.The Ministry of Health and Welfare announced the "Pediatric Essential Medical Care Fee Plan" on Friday at a regular briefing of the Central Disaster and Safety Headquarters.Since last
Students from 40 medical schools nationwide have set about to file a class action lawsuit against the government to prevent the government from increasing the medical school enrollment quota.The Korean Association of Medical Colleges and Medical Graduate Schools (KAMC) has begun recruiting participa
After the plans to integrate Hanmi Group with OCI Holdings fell through, Hanmi officials withdrew from their nominations as internal directors at OCI Holdings.This development came ahead of OCI Holdings’ annual shareholders' general meeting on Friday, signaling a significant shift in the relationshi
On a bustling afternoon on Thursday, just minutes past 3:00 p.m., an outpour of cheers erupted from the crowd-packed SINTEX Hall in Suwon Science College in Suwon, Gyeonggi Province.The applause and shouts nearly blew the speakers in the press room as the two-month-long managerial dispute within the
The International Labor Organization (ILO) said it has intervened with the Korean government regarding Seoul’s order for trainee doctors to start work and called for it to resolve the issue through social dialogue.In response, the government said it would sincerely explain its position to the intern
The Ministry of Food and Drug Safety (MFDS) has warned consumers to be cautious about directly purchasing some foreign health supplements through online shopping malls at home and abroad.The ministry inspected 30 products for the spring season targeting the improvement of fine dust, respiratory, and
Starting April 1, Soliris, a complement C5 inhibitor, will be reimbursed for neuromyelitis optica spectrum disorder (NMOSD), expanding its health insurance coverage beyond paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).On Friday, AstraZeneca Korea announced t
Starting next month, health insurance benefits will be applied to treating metastatic breast and gastric cancers with Enhertu (trastuzumab deruxtecan) in Korea. On Thursday, the Ministry of Health and Welfare convened the Health Insurance Policy Deliberation Committee and approved the revised “Drug
D&D Pharmatech said Thursday that DD01, an injectable treatment for metabolic-associated steatohepatitis (MASH) being developed by the company, has received fast-track designation from the U.S. Food and Drug Administration. This is the second MASH treatment developed by a Korean company to receive t
CHA Biotech and Centenaire Biosciences have agreed to expand their collaboration on natural killer (NK) cell-antibody combination research. To this end, CHA Biotech transferred its NK cell therapeutic candidate to Centenaire Biosciences.The two companies will combine CHA Biotech's NK cells with Cent
In a pivotal shareholders' meeting of Hanmi Science on Thursday, the control tower within the Hanmi Group, the sons --Coree Group Chairman Lim Jong-yoon and Hanmi Fine Chemical CEO Lim Jong-hoon -- of the founding family secured a significant victory in the boardroom struggle against their mother an
Korean researchers have analyzed the effects of nanolastics on the metabolism of offspring.The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said its research team, led by Dr. Lee Da-yong of the Center for Rare and Difficult Diseases, has found that nanoplastics are transferred to
The treatment of biliary tract cancer, one of the cancers with a poor prognosis, is changing rapidly. Immunotherapies and targeted anticancer drugs have been developed in a rush. However, none of them have been covered by health insurance in Korea, and patients and medical workers complain that the
Celltrion, a Korean biopharmaceutical giant, said it has launched a 20-mg dosage formulation of its biosimilar Yuflyma (adalimumab) to treat autoimmune diseases in pediatric patients in the U.S.Yuflyma 20mg is the same high-concentration (100mg/mL) formulation as the 40mg and 80 mg, which were launc
Coreline Soft, a medical AI company, has begun to generate results by strengthening its solution supply contracts and partnerships with leading European hospitals.Coreline Soft said Thursday that it has signed a contract to supply its flagship product, AVIEW LCS Plus, a simultaneous diagnosis soluti
Medical school professors repeatedly point out that the government's decision to increase in the medical school enrollment quota will compromise the quality of medical education.Some experts have gone so far as to express concerns that such actions could regress medical education by a century.As par
Takeda Pharmaceuticals Korea said on Thursday that Livtencity (ingredient: maribavir), a tablet for cytomegalovirus (CMV) infection and disease after transplantation, will be covered by Korean national health insurance starting April 1.Livtencity is an antiviral pill developed to treat CMV infection
There are no foods that you shouldn’t eat in the morning. A common concern is that eating a banana on an empty stomach in the morning will cause magnesium and potassium to enter the blood, upsetting the balance. However, there is no evidence to support this claim. One banana contains 300 mg of potas
Trainee pediatricians who have left hospitals have come forward to demand a fundamental package to resuscitate essential medicine. They say they could not help but quit to block the government's wrong policies.Interns and residents who walked off their jobs at pediatrics departments at 18 major hosp
HK inno.N said it plans to present the interim preclinical research findings on IN-119873, its next-generation allosteric EGFR-tyrosine kinase inhibitor (EGFR-TKI) candidate, targeting non-small cell lung cancer (NSCLC) patients with the L858R genetic mutation, during the upcoming annual meeting of